Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway

Published:2021-07 Issue: Volume:96 Page:107771
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Chen Xiaoling,Ma Jing,Yao Yajie,Zhu Jiawei,Zhou Zhihan,Zhao Rui,Dong Xiaoqing,Gao Wei,Zhang Shuangquan,Huang Shile,Chen Long

Funder

American Cancer Society

National Natural Science Foundation of China

Priority Academic Program Development of Jiangsu Higher Education Institutions

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference59 articles.

1. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens;Shu;J. Leukoc. Biol.,1999

2. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase;Mukhopadhyay;J. Biol. Chem.,1999

3. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator;Moore;Science,1999

4. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease;Gross;Nature,2000

5. BAFF AND APRIL: a tutorial on B cell survival;Mackay;Annu. Rev. Immunol.,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin as a Therapeutic Agent for Obesity-Associated Immune Dysfunction;The Journal of Nutrition;2024-08

2. Jiedu-Quyu-Ziyin Fang (JQZF) inhibits the proliferation and activation of B cells in MRL/lpr mice via modulating the AKT/mTOR/c-Myc signaling pathway;Journal of Ethnopharmacology;2023-10

3. Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming;Cellular and Molecular Life Sciences;2023-09-09

4. Regulation of the immune system by the insulin receptor in health and disease;Frontiers in Endocrinology;2023-03-13

5. Quo vadis PGRMC? Grand-Scale Biology in Human Health and Disease;Frontiers in Bioscience-Landmark;2022-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3